| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0008 |